Literature DB >> 3495456

Histidine-rich glycoprotein is evolutionarily related to the cystatin superfamily. Presence of two cystatin domains in the N-terminal region.

T Koide, S Odani.   

Abstract

A new member of the cystatin superfamily is introduced. Human plasma histidine-rich glycoprotein (HRG) was found to contain 2 cystatin-like sequences in tandem in the N-terminal region. Domain 1 (residues 1-112) was most homologous to domain 1 of the heavy chain of human kininogen and domain 2 (residues 113-225) was most homologous to human cystatin S as well as other cystatins and domain 3 of the heavy chain of kininogen, suggesting that the cystatin domains of HRG may represent a hitherto unknown binary form (or intermediate molecule) composed of 2 cystatin domains, and evolutionarily intermediate between the cystatin and the kininogen families.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495456     DOI: 10.1016/0014-5793(87)80748-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Evolution of proteins of the cystatin superfamily.

Authors:  N D Rawlings; A J Barrett
Journal:  J Mol Evol       Date:  1990-01       Impact factor: 2.395

2.  Association of purified skeletal-muscle AMP deaminase with a histidine-proline-rich-glycoprotein-like molecule.

Authors:  M Ranieri-Raggi; U Montali; F Ronca; A Sabbatini; P E Brown; A J Moir; A Raggi
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

3.  Immunohistochemical analysis of human skeletal muscle AMP deaminase deficiency. Evidence of a correlation between the muscle HPRG content and the level of the residual AMP deaminase activity.

Authors:  Antonietta R M Sabbatini; Antonio Toscano; Mohammed Aguennouz; Daniela Martini; Enza Polizzi; Maria Ranieri-Raggi; Arthur J G Moir; Alba Migliorato; Olimpia Musumeci; Giuseppe Vita; Antonio Raggi
Journal:  J Muscle Res Cell Motil       Date:  2006-03-29       Impact factor: 2.698

4.  Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1.

Authors:  R Simantov; M Febbraio; R Crombie; A S Asch; R L Nachman; R L Silverstein
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

5.  Rat tyrosine kinase inhibitor shows sequence similarity to human alpha 2-HS glycoprotein and bovine fetuin.

Authors:  M Haasemann; P Nawratil; W Müller-Esterl
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

6.  Crystal structure of histidine-rich glycoprotein N2 domain reveals redox activity at an interdomain disulfide bridge: implications for angiogenic regulation.

Authors:  Omar Kassaar; Stephen A McMahon; Rory Thompson; Catherine H Botting; James H Naismith; Alan J Stewart
Journal:  Blood       Date:  2014-02-05       Impact factor: 22.113

7.  Protein and site specificity of fucosylation in liver-secreted glycoproteins.

Authors:  Petr Pompach; David J Ashline; Zuzana Brnakova; Julius Benicky; Miloslav Sanda; Radoslav Goldman
Journal:  J Proteome Res       Date:  2014-10-10       Impact factor: 4.466

8.  Purification of rabbit serum histidine-proline-rich glycoprotein via preparative gel electrophoresis and characterization of its glycosylation patterns.

Authors:  Anna Katharina Weyrauch; Mario Jakob; Angelika Schierhorn; Ralf Bernd Klösgen; Dariush Hinderberger
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

9.  Histidine-rich glycoprotein can prevent development of mouse experimental glioblastoma.

Authors:  Maria Kärrlander; Nanna Lindberg; Tommie Olofsson; Marianne Kastemar; Anna-Karin Olsson; Lene Uhrbom
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

10.  Anti-Angiogenic and Anti-Proliferative Graphene Oxide Nanosheets for Tumor Cell Therapy.

Authors:  Valeria Verde; Anna Longo; Lorena Maria Cucci; Vanessa Sanfilippo; Antonio Magrì; Cristina Satriano; Carmelina Daniela Anfuso; Gabriella Lupo; Diego La Mendola
Journal:  Int J Mol Sci       Date:  2020-08-04       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.